The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125362241 12536224 1 I 20160508 20160704 20160707 20160707 EXP FR-GLAXOSMITHKLINE-FR2016GSK096615 GLAXOSMITHKLINE 61.17 YR M Y 0.00000 20160707 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125362241 12536224 1 PS ZOVIRAX ACYCLOVIR 1 UNK Y 18603
125362241 12536224 2 SS OXYNORM OXYCODONE HYDROCHLORIDE 1 Intravenous (not otherwise specified) UNK Y 0
125362241 12536224 3 SS ALPRAZOLAM. ALPRAZOLAM 1 Oral 0.5 MG, SINGLE 0 .5 MG TABLET
125362241 12536224 4 C STILNOX ZOLPIDEM TARTRATE 1 Oral UNK Y 0
125362241 12536224 5 C TIAPRIDAL TIAPRIDE HYDROCHLORIDE 1 UNK Y 0 SOLUTION FOR INJECTION
125362241 12536224 6 C Melphalan MELPHALAN 1 UNK U 0
125362241 12536224 7 C VELCADE BORTEZOMIB 1 UNK 0
125362241 12536224 8 C CAELYX DOXORUBICIN HYDROCHLORIDE 1 UNK 0
125362241 12536224 9 C REVLIMID LENALIDOMIDE 1 UNK U 0
125362241 12536224 10 C DEXAMETHASONE. DEXAMETHASONE 1 UNK U 0
125362241 12536224 11 C ENDOXAN CYCLOPHOSPHAMIDE 1 UNK U 0
125362241 12536224 12 C TAZOCILLINE PIPERACILLIN SODIUMTAZOBACTAM SODIUM 1 4 G, SINGLE 0 4 G
125362241 12536224 13 C Triflucan FLUCONAZOLE 1 Intravenous (not otherwise specified) 400 MG, TID 7200 MG Y 0 400 MG TID
125362241 12536224 14 C Zelitrex VALACYCLOVIR HYDROCHLORIDE 1 UNK 0
125362241 12536224 15 C BACTRIM SULFAMETHOXAZOLETRIMETHOPRIM 1 1 UNK, Z 0 1 DF TABLET
125362241 12536224 16 C EFFEXOR VENLAFAXINE HYDROCHLORIDE 1 37.5 MG, 1D U 0 37.5 MG PROLONGED-RELEASE TABLET QD
125362241 12536224 17 C LYRICA PREGABALIN 1 100 MG, BID U 0 100 MG BID
125362241 12536224 18 C XANAX ALPRAZOLAM 1 0.5 MG, SINGLE 0 .5 MG
125362241 12536224 19 C PHOCYTAN .ALPHA.-GLUCOSE-1-PHOSPHATE 1 UNK U 0
125362241 12536224 20 C Mopral OMEPRAZOLE SODIUM 1 20 MG, 1D U 0 20 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125362241 12536224 1 Prophylaxis
125362241 12536224 2 Mucosal inflammation
125362241 12536224 3 Anxiety
125362241 12536224 4 Insomnia
125362241 12536224 19 Hypophosphataemia

Outcome of event

Event ID CASEID OUTC COD
125362241 12536224 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125362241 12536224 Confusional state
125362241 12536224 Hallucination
125362241 12536224 Neurotoxicity

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125362241 12536224 1 20160502 20160510 0
125362241 12536224 2 20160504 20160508 0
125362241 12536224 3 20160507 20160507 0
125362241 12536224 4 20160510 0
125362241 12536224 5 20160508 20160508 0
125362241 12536224 6 20160429 0
125362241 12536224 7 201503 0
125362241 12536224 8 201503 0
125362241 12536224 9 2016 0
125362241 12536224 10 2016 0
125362241 12536224 11 2016 0
125362241 12536224 12 20160506 20160506 0
125362241 12536224 13 20160502 20160510 0
125362241 12536224 14 2016 0
125362241 12536224 15 2016 0
125362241 12536224 18 20160507 20160507 0
125362241 12536224 19 201605 0